FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/04/042117 [Registered on: 25/04/2022] Trial Registered Prospectively
Last Modified On: 22/04/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [curative]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study to find out the effect of shirodhara with balaswagandhadi taila,rasayan churna vati and lifestyle modification in post menopausal women 
Scientific Title of Study   Randomized study to evaluate the role of lifestyle modificatiion,rasayan churna vati and shirodhara in postmenopausal women - An open label comparitive clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Athira k 
Designation  PG scholar 
Affiliation  All India Institute of Ayurveda 
Address  Room no 405,4 th floor, Academic block, All India Institue of Ayurveda, Goutampuri, Saritavihar,New Delhi

South
DELHI
110076
India 
Phone  9947150302  
Fax    
Email  athirachandran1442@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kamini Dhiman 
Designation  Associate professor 
Affiliation  All India Institute Of Ayurveda 
Address  room no 402, 4 th floor,Academic block, All India Institue of Ayurveda, Goutampuri, Saritavihar,New Delhi

South
DELHI
110076
India 
Phone  8920900968  
Fax    
Email  kd44ayu@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Kamini Dhiman 
Designation  Associate professor 
Affiliation  All India Institute Of Ayurveda 
Address  room no 402, 4 th floor,Academic block, All India Institue of Ayurveda, Goutampuri, Saritavihar,New Delhi

South
DELHI
110076
India 
Phone  8920900968  
Fax    
Email  kd44ayu@yahoo.co.in  
 
Source of Monetary or Material Support  
all india institute of ayurveda 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  All India Institute Of Ayurveda,Goutampuri,Saritavihar,New Delhi,110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Athira k  All India Institute Of Ayurveda  All india institute of ayurveda,Goutamuri,saritavihar,New Delhi,110076
South
DELHI 
9947150302

athirachandran1442@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC - AIIA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N00-N99||Diseases of the genitourinary system, (2) ICD-10 Condition:N952||Postmenopausal atrophic vaginitis. Ayurveda Condition: rajonirvrtti,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: rasayanchurnavati, Reference: ashtangahrdayam uttarastana, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Comparator ArmProcedure-shirodhara (Procedure Reference: sahasrayoga, Procedure details: shirodhara with balaswagandhadi taila for a duration of 21 days schedule with 5 days shirodhara session of 30 minutes with 3 days gap in beyween )
(1) Medicine Name: rasayan churnavati, Reference: ashtangahrdaya uttarastana, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 3(g), Frequency: bd, Duration: 21 Days
3Comparator ArmLifestyle--Dinacarya: according to prakriti, Ritucarya: according to ritu, Acara Rasayana:, Other:, Pathya/Apathya:no, Pathya:, Apathya:
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  75.00 Year(s)
Gender  Female 
Details  1. women who have cessation of menstruation for 1 year or more
2. women fulfilling diagnostic criteria of menopausal syndrome
3. postmenopausal women with symptoms of menopausal syndrome, who are willing to prticipate in the study 
 
ExclusionCriteria 
Details  1. Postmenopausal women who had previos exposure to therapieseg; yoga and panchakarma procedures taken within 3 months.
2. postmenopausal women who are undergoing hormonal replacement therapy
3. patients suffering from any major illness, eg; cancer, diabetis mellitus,cardiac disorerstuberculosis etc
4. Patients having surgical menopause 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Impovement in symptoms will be assessed using kupperman index and menopause rating scale  21 days 
 
Secondary Outcome  
Outcome  TimePoints 
to see change in quality of life of postmenopausal women  2 months intervention and 2 months follow up 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   29/04/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Menopause is one of the most important phases of life of a woman. It is defined as permanent  cessation of menstruation at the end of reproductive life due to loss of ovarian follicular  activity1. It is a natural process that happens to every woman as she grows older and not a  medical problem, disease or illness, even though it may appear so2.

CLASSICAL 

According to ayurvedic classics, while describing physiology of menstruation, it is mentioned  that complete cessation of menstruation occurs at the age of 50 years. 6 

 By this time women in reproductive phase of life having pitta predominance terminates  into the vata phase of life.7It is also mentioned as a kshaya stage of life due to aging process.  Kshaya of dhathus, mainly rasa dhathu will ultimately leads to raja kshaya which is  considered to be the byproduct of the former. Raja itself is a physiological entity which is  having swabhava of degradation and ultimately manifests as rajonirvritti. Diminition of  dhathus will manifests in woman as various anatomical and psychological symptoms and  they are described as menopausal syndrome in modern medical science.  

INVESTIGATIONS 

A. Routine Blood investigations including CBC, TFT, lipid profile , LFT , KFT , Blood  sugar 

B. Urine for routine and microscopic examination 

C. Hormonal essay for FSH and LH 

D. USG

16 

GROUPING AND DRUG DELIVERY REGIME 

S.NO 

Group 

Description 

Dose & Duration

Group A 

Lifestyle modifications.


Group B 

1.Rasayan churna vati 

2.Lifestyle modifications

3 tablets twice a day with lukewarm  water , daily after meals for 21 days

Group C 

1.Abhyanga(Tila taila -15  minutes),swedana(Sarawanga  swedana by Dashamool  kashaya for 5 -7 minutes)  Shirodhara with  Balaswhagandhadi taila. 

2.Rasayan churna vati 

3.Lifestyle modifications

1) 21 days schedule with 5 days  Shirodhara sessions of 30 minutes with  3 days break in between will be  advocated (i. e 3 cycles of 5 days each). 

2) 3 tablets twice a day with lukewarm  water , daily after meals for 21 days. 



Lifesstyle modification as per the previous study will be advised to patient and also relatives  and will make sure they are doing it by regular follow up.  

FOLLOW UP 

At the interval of 2 weeks for 2 months after completion of the treatment.

17 

WITHDRAWAL CRITERIA 

1) If patient is unwilling to continue the selective procedure. 

2) If patient is allergic / sensitive to selective procedures. 


 
Close